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Background: Role of neutrophil lymphocyte ratio (NLR) in predicting cardiovascular events has not been studied in general population.
objective: To see if NLR adds to Framingham risk score (FRS) for prediction of coronary heart disease (CHD) mortality in a nationally representative 
cohort.
methods: We included 6,413 subjects of NHANES-III cohort, aged 30-79 years, without prior history of CHD or CHD equivalent, with mean follow-up 
of 14.1 years. We excluded subjects with malignancies, chronic inflammatory & autoimmune disorders. Cox proportional hazards model was used to 
predict CHD mortality. Two models were created incorporating FRS covariates with & without NLR, & were compared using discrimination, calibration 
& net reclassification index (NRI).
results: NLR was an independent predictor of CHD mortality with adjusted hazards ratio 1.3, 95% confidence interval (CI) 1.1-1.5, p<0.01. With 
addition of NLR to FRS model, overall NRI was 6.9% (95% CI 1.9% to 11.8%, p<0.01), event NRI was 5.7% (p=0.02) & non-event NRI was 1% 
(p<0.01). Absolute integrated discrimination index (IDI) was 0.004 (p=0.04) & relative IDI was 4.9%. Model with NLR showed improved C-index 
(0.8731 vs. 0.8717) & area under curve (0.8575 vs. 0.8560), albeit statistically non-significant (p>0.05). Hosmer-Lemeshow chi-square was 8.38 
(<20) & likelihood ratio test was significant (p<0.01) in model with NLR, consistent with better calibration.
conclusion: Addition of NLR to FRS significantly improves prediction of mortality from CHD.
CHD mortality and Net Reclassification Index (NRI) in models with and without NLR
Model with FRS covariates without NLR Model with FRS covariates plus Neutrophil lymphocyte ratio (NLR)
<5% 5-10% 10 - 20% >=20% Total Higher reclassification Lower reclassification
Subjects with CHD events
<5% 51 4 0 0 55 4 NA
5-10% 0 46 4 0 50 4 0
10 - 20% 0 2 49 9 60 9 2
>=20% 0 0 4 23 27 NA 4
Total 51 52 57 32 192 17 6
NRI for events 0.0573, p=0.022
Subjects without CHD events
<5% 4,928 32 1 1 4,962 34 NA
5-10% 65 488 34 0 587 34 65
10 - 20% 0 57 307 14 378 14 57
>=20% 0 0 14 73 87 NA 14
Total 4,993 577 356 88 6,014 82 136
NRI for non-events 0.009, p<0.001
Overall NRI 0.0686, 95% CI 0.0194 to 0.1178, p=0.006
